TerrAscend reported revenue of C$1.8 million as it followed through on supply deals for adult-use bulk product to Canadian provinces.
However, on Wednesday’s trading session, shares of the company were down 2.23 percent. The stock reached a high of C$7.42 during the day but ended up settling with a price of C$7.
At the end of the quarter, TerrAscend also reported a loss of C$2.8 million which represents a C$0.03 loss per share.
The company’s losses were dominated by its controlling interests. At the end of the quarter the company held a C$15.1 million cash and equivalents stash.
“TerrAscend’s goal is to become the leading multi-state operator in the US cannabis industry while continuing to capitalize on sizeable opportunities in Canada and the rest of the world,” Michael Nashat, TerrAscend’s president and CEO, said in a statement.
In October the company revealed its intentions to gain a presence in the fractured US cannabis market.
An estimate from Haywood Securities indicates the US cannabis market will be worth US$23 billion in 2025.
Launching a vertically integrated multi-state operator of cannabis assets in the US has become a popular play and has started to attract the attention of investors.
TerrAscend is in the unique position as itcounts with the backing from one of the biggest Canadian licensed producers (LPs) around.
Companies on the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) are not permitted to directly have assets in the US cannabis market due to the federal illegality of the drug.
However, the two investing companies shuffled the actual investment through a change in the shares being purchased.
As explained by Alan Brochstein, cannabis analyst with 420 Investor, Canopy Growth and Canopy Rivers swapped the equity stakes gained for “exchangeable shares” which don’t allow voting rights or dividends.
“In the future, if the rules for the TSX change, which could happen without full legalization, or if cannabis is legalized federally, then Canopy and Canopy Rivers will be able to convert their securities into common shares,” Brochstein wrote in his weekly column to investors.
In a previous statement Bruce Linton, acting CEO of Canopy Rivers and co-CEO of Canopy Growth, said the restructuring was done in order to “create long-term value for our shareholders as it positions the Company with optionality and conditional future exposure to a significant new market.”
According to the full financial report, neither of the companies TerrAscend has invested in for the US market — Well and Good and Neta NJ — will start operations until the reorganization with its key investees is complete.
Recreational market shows growth in report
Nashat said the company’s premium brand “Haven St.” has started to “resonate” with consumers in Canada.
The company started selling medical cannabis in April according to company documents.
Based on 11 reviews in the cannabis review site from Lift & Co. (TSXV:LIFT), the brand has a 4 star rating.
In Ontario, the brand counts with eight different products available on the OCS online store.
As of September 30, the company counted with 2,066 cannabis plants as its biological assets. The company reported owning C$4,742 worth of externally purchases cannabis oils.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).